Last update:

Vaccination news


Updated booster shots, not original COVID vaccines, should be standard: FDA panel

The U.S. Food and Drug Administration's vaccine advisory panel on Thursday voted unanimously to recommend that the agency phase out original versions of COVID vaccines for use in the unvaccinated, in favor of updated bivalent ...


COVID booster vaccines: How a third dose may help vulnerable people 'level up' their immunity

COVID vaccines call our immune systems to action, generating antibodies which fight against any contact we have with the virus. Antibodies help to reduce the effects of an infection or even prevent it altogether. Scientists ...

Diseases, Conditions, Syndromes

COVID-19 vaccine based on new technology tested in clinical study

A new COVID-19 vaccine based on a different platform than current vaccines on the market has been tested in humans for the first time by researchers at Radboud university medical center. Administration of this vaccine in ...


Vaccine misinformation spawns 'pure blood' movement

Vaccine skeptics blocking transfusions for life-saving surgeries, Facebook groups inciting violence against doctors and a global search for unvaccinated donors—COVID-19 misinformation has bred a so-called "pure blood" movement.


How much of a boost do 'booster' COVID-19 jabs give?

Scientists have found the "booster" COVID-19 vaccine program led to a large boost in the antibodies that help protect against coronavirus. High levels of antibodies is associated with lower risk of severe infection.

Diseases, Conditions, Syndromes

COVID is running rampant in China—but herd immunity remains elusive

After nearly three years of keeping COVID under control, China is experiencing a massive new wave of COVID infections. The official figures reporting 60,000 deaths between December 8 and January 12 are widely seen as underestimating ...


Children's early flu toll shows dangers of vaccine hesitancy

Children have been hit especially hard by the early-onset flu season, according to a study from Tennessee that raises concerns about U.S. immunization rates following the pandemic-fueled trend of vaccine hesitancy.


Nine common questions about vaccines and travel

Travel does more than just transport you to a different place. It can broaden your perspective, increase your happiness, give you a chance to try new things, boost your creativity and help you recharge. Even planning a trip ...

Diseases, Conditions, Syndromes

Moderna reports positive results for RSV vaccine

US biotech company Moderna on Tuesday announced positive interim trial results for its vaccine against respiratory syncytial virus (RSV) in adults over the age of 60.


Push to develop mRNA vaccine patches

The global epidemic innovations fund said Tuesday it was working with a vaccine manufacturer to create a patch using mRNA technology, which would be easier to use against COVID.

Medical economics

Paying people to take COVID vaccine worked well, study finds

A study finds that paying people to take a first dose of a COVID-19 vaccine didn't lower the likelihood of seeking the second or third dose or of other positive health behaviors and didn't erode morals, sense of civic duty, ...


Vaccination coverage down in kindergarteners during 2021 to 2022

For children in kindergarten, vaccination coverage was lower for all vaccines in the 2021 to 2022 school year compared with the 2020 to 2021 school year, according to research published in the Jan. 13 issue of the U.S. Centers ...


Vaccine coverage by age 24 months unchanged during pandemic

Vaccine coverage by age 24 months was generally similar during the pandemic versus prepandemic, but coverage disparities remain, according to research published in the Jan. 13 issue of the U.S. Centers for Disease Control ...

Diseases, Conditions, Syndromes

Weak spot in COVID could guide vaccine advances

After three years of infections, lockdowns, and vaccinations, we know a lot about SARS-CoV-2, the virus that causes COVID-19—but we don't know everything. Like, why are some variants weaker than others? Why does the omicron ...

Medical research

Developing mucosal vaccines for respiratory viruses

Vaccines that provide long-lasting protection against influenza, coronaviruses and respiratory syncytial virus (RSV) have proved exceptionally difficult to develop. In a new review article in Cell Host & Microbe, researchers ...


Pharma lobby blasts 'stupid' pandemic patent plans

Stripping patent protection from COVID-19 treatments is a "mind-bogglingly stupid" idea, the head of a leading pharmaceutical lobby said Wednesday, warning that the move would put industry innovation at risk.

Diseases, Conditions, Syndromes

Waning immunity most consistent with recent mumps outbreaks

A waning immunity model is most consistent with recently observed resurgent outbreaks of mumps in countries with high vaccine coverage, according to a study published online Jan. 9 in the Proceedings of the National Academy ...